BiomX : CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2022

CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022


CONTENTS








Page




...

Related Keywords

Delaware , United States , Connecticut , Ness Ziona , Hamerkaz , Israel , Credit On , Devon , United Kingdom , Japan , American , America , State Of Israel , Israeli , Kesselman , Stock Exchange , Boehringer Ingelheim International Gmb , Biomx Inc , Securities Exchange , Company Common Stock , Company Ability To , Pricewaterhousecoopers International , Cystic Fibrosis Foundation Cf , World Health Organization On , Maruho Co , Company Primary Sclerosing Cholangitis , Israel Innovation Authority , Rondinx Ltd , Company Phase , Company On , Exchange Commission On , Leumi Bank Israel , Keio University , Exchange Commission , United Kingdom Financial Conduct Authority , Aviv Stock Exchange , Public Accounting Firm , Public Company Accounting Oversight Board United States , Hercules Capital Inc , Company Board Of Directors The , Company Or Biom , Cf Foundation , Yeda Research , Biomx Ltd , Most Of The Company , Development Company Limited Yeda , Massachusetts Institute Of Technology , Consolidated Financial , Independent Registered Public Accounting , Public Company Accounting Oversight Board , Public Accountants , Pricewaterhousecoopers International Limited , Common Stock , Open Market Sales Agreement , Securities Purchase Agreement , Stock Purchase Agreement , Biomx Israel , Tel Aviv Stock , Tel Aviv Stock Exchange , World Health Organization , Value Measurements , Cystic Fibrosis Foundation , Severance Compensation Act , Israeli Severance Compensation Act , Internal Revenue , Liabilities From , Accounting Standards Codification , Based Payment , Accounting Standards Update , Jumpstart Our Business Startups Act , Own Equity , Accounting For Convertible Instruments , Per Share , Certain Modifications , Freestanding Equity Classified Written Call , Financial Accounting Standards Board , Instruments Credit Losses Measurement , Financial Instruments , Securities Exchange Act , Contract Assets , Contract Liabilities , Leumi Bank , Inflammatory Bowel Disease , Primary Sclerosing Cholangitis , Through December , Financial Conduct Authority , License Agreement , Development Company Limited , Yeda Amendment , Recapitalization Transaction , Exit Fee , Massachusetts Institute , Patent License Agreement , Agreement Effective , Boehringer Ingelheim International Gmbh , First Agreement Effective Date , Final Report , Second Agreement Effective Date , Security Agreement , Hercules Capital , Loan Agreement , Term Loan Facility , Prime Rate , Wall Street Journal , Term Charge , Public Offering , Public Units , Public Unit , Public Warrants , Sales Agreement , Open Market Issuance Sales Agreement , Additional Paid , Purchase Agreement , Milestone Payment , Private Placement Warrants , Direct Offering Warrants , Incentive Plan , Ordinary Share , Israeli Income Tax Ordinance , Revenue Code , Corporate Restructuring , Pre Funded Warrants , Long Term Incentive Plan , Israeli Government , Security Cabinet , Stock Option Plan , Markets ,